Prostate cancer screening in a low prevalence population

References

1. ↵
   1. World Health Organization

   Early detection of cancer, from URL: http://www.who.int/cancer/detection/en/. Accessed 2017 January 10.
2. ↵
   1. Moyer VA

   (2012) U.S. Preventive Services Task Force. Screening for prostate cancer:U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 157:120–134.

   OpenUrlCrossRefPubMedWeb of Science
3. ↵
   1. Chou R,
   2. Croswell JM,
   3. Dana T,
   4. Bougatsos C,
   5. Blazina I,
   6. Fu R,
   7. et al.

   (2011) Screening for prostate cancer:a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 155:762–771.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   1. Resnick MJ,
   2. Koyama T,
   3. Fan KH,
   4. Albertsen PC,
   5. Goodman M,
   6. Hamilton AS,
   7. et al.

   (2013) Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med 368:436–445.

   OpenUrlCrossRefPubMedWeb of Science
5. ↵
   1. Johansson E,
   2. Steineck G,
   3. Holmberg L,
   4. Johansson J,
   5. Nyberg T,
   6. et al.

   (2011) Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting:the Scandinavian Prostate Cancer Group-4 randomised trial. Lancet Oncol 12:891–899.

   OpenUrlCrossRefPubMedWeb of Science
6. ↵
   1. International Agency for Research on Cancer. World Health Organization

   GLOBOCAN 2012:Estimated Incidence, Mortality, and Prevalence Worldwide in 2012. All Cancers (excluding non-melanoma skin cancer), Available from URL: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. Accessed 2017 March 15.
7. ↵
   1. Council of health services, Saudi Cancer registry

   Cancer Incidence Report. Saudi Arabia, Available from URL: http://chs.gov.sa/En/HealthCenters/Pages/default.aspx. Accessed 2017 January 1.
8. ↵
   1. Alghamidi IG,
   2. Hussain II,
   3. Alghamdi MS,
   4. El-Sheemy MA

   (2014) The incidence rate of prostate cancer in Saudi Arabia:an observational, descriptive epidemiological analysis of data from the Saudi Cancer Registry 2001-2008. Hematol Oncol Stem Cell Ther 7:18–26.

   OpenUrl
9. ↵
   1. Arafa MA,
   2. Rabah DM,
   3. Wahdan IH

   (2012) Awareness of general public towards cancer, prostate and screening practice in arabic communities:a comparative multi-center study. Asian Pac J Cancer Prev 13:4321–4326.

   OpenUrlPubMed
10. ↵
    1. Roberts A

    Barriers preventing early detection of prostate cancer in black African/Caribbean men living in Westminster, Available from URL: http://docplayer.net/17946403-Barriers-preventing-early-detection-of-prostate-cancer-in-black-african-caribbean-men-living-in-westminster.html. Updated 2010;Accessed 2016 November 1.
11. ↵
    1. Smith CJ

    (2012) Diagnostic tests - sensitivity and specificity. Phlebology 27:250–151.

    OpenUrlCrossRefPubMed
12. ↵
    1. Rabah DM,
    2. Arafa MA

    (2010) Prostate cancer screening in a Saudi population:an explanatory trial study. Prostate Cancer Prostatic Dis 13:191–194.

    OpenUrlPubMed
13. ↵
    1. Schröder FH,
    2. Hugosson J,
    3. Roobol MJ,
    4. Tammela TL,
    5. Ciatto S,
    6. Nelen V,
    7. et al.

    (2009) Screening and prostate cancer mortality in a randomized European study. N Engl J Med 360:1320–1328.

    OpenUrlCrossRefPubMedWeb of Science
14. ↵
    1. Sandhu GS,
    2. Andriole GL

    (2012) Over diagnosis of prostate cancer. J Natl Cancer Inst Monogr (45):146–151.
15. ↵
    1. Carter HB,
    2. Albertsen PC,
    3. Barry MJ,
    4. Etzioni R,
    5. Freedland SJ,
    6. Kirsten Lynn Greene,
    7. et al.

    Early detection of Prostate cancer:AUA Guideline, Available from URL: https://www.auanet.org/education/guidelines/prostate-cancer-detection.cfm. Updated 2013; Accessed 2016 December 28.
16. ↵
    1. Pinsky PF,
    2. Prorok PC,
    3. Kramer BS

    (2017) Prostate Cancer Screening - A Perspective on the Current State of the Evidence. N Engl J Med 376:1285–1289.

    OpenUrlCrossRefPubMed
17. ↵
    1. Xiaomei Ma,
    2. Wang R,
    3. Long JB,
    4. Ross JS,
    5. Soulos PR,
    6. James B. Yu,
    7. et al.

    (2014) The cost implication of prostate cancer screening in The Medicare population. Cancer 120:96–102.

    OpenUrlPubMed
18. ↵
    1. Shteynshlyuger A,
    2. Andriole GL

    (2011) Cost-effectiveness of prostate specific antigen screening in the United States:Extrapolating from the European study of screening for prostate cancer. J Urol 185:828–832.

    OpenUrlCrossRefPubMedWeb of Science
19. ↵
    1. Heijnsdijk EA,
    2. de Carvalho TM,
    3. Auvinen A,
    4. Zappa M,
    5. Nelen V,
    6. Kwiatkowski M,
    7. et al.

    (2014) Cost-effectiveness of prostate cancer screening:a simulation study based on ERSPC data. J Natl Cancer Inst 107:366.

    OpenUrlCrossRefPubMed
20. ↵
    1. Martin RM

    (2007) Prostate cancer is omnipresent, but should we screen for it? Int J epidemiol 36:278–281.

    OpenUrlCrossRefPubMed